Filing Details

Accession Number:
0001181431-13-053974
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-10-16 12:26:51
Reporting Period:
2013-05-17
Filing Date:
2013-10-16
Accepted Time:
2013-10-16 12:26:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1131543 Ambit Biosciences Corp AMBI Pharmaceutical Preparations (2834) 330909648
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1562157 Foresite Capital Fund I, L.p. 3052 Pacific Avenue
San Francisco CA 94115
No No Yes No
1581219 Foresite Capital Management I, Llc 3052 Pacific Avenue
San Francisco CA 94115
No No Yes No
1581754 B. James Tananbaum 3052 Pacific Avenue
San Francisco CA 94115
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-05-17 36,616 $6.77 2,036,616 No 4 P Indirect See footnote
Common Stock Acquisiton 2013-05-20 8,120 $6.90 2,044,736 No 4 P Indirect See footnote
Common Stock Acquisiton 2013-05-21 1,811 $6.84 2,046,547 No 4 P Indirect See footnote
Common Stock Acquisiton 2013-05-22 5,005 $6.74 2,051,552 No 4 P Indirect See footnote
Common Stock Acquisiton 2013-06-03 10,000 $6.99 2,061,552 No 4 P Indirect See footnote
Common Stock Acquisiton 2013-06-12 5,700 $7.45 2,067,252 No 4 P Indirect See footnote
Common Stock Acquisiton 2013-06-14 7,500 $7.46 2,074,752 No 4 P Indirect See footnote
Common Stock Acquisiton 2013-06-24 4,817 $6.77 2,079,569 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
No 4 P Indirect See footnote
No 4 P Indirect See footnote
No 4 P Indirect See footnote
No 4 P Indirect See footnote
No 4 P Indirect See footnote
No 4 P Indirect See footnote
No 4 P Indirect See footnote
Footnotes
  1. Shares are owned directly by Foresite Capital Fund I, L.P. ("FCF I"). Foresite Capital Management I, LLC ("FCM I"), the Designated Filer and general partner of FCF I, may be deemed to have the sole voting and dispositive power over 2,074,752 shares of the Issuer's Common Stock. James Tananbaum ("Tananbaum"), in his capacity as managing member of FCM I, may be deemed to have the sole voting and dispositive power over 2,074,752 shares of the Issuer's Common Stock.